The progress and prospects of targeting the adenosine pathway in cancer immunotherapy
Abstract Despite the notable success of cancer immunotherapy, its effectiveness is often limited in a significant proportion of patients, highlighting the need to explore alternative tumor immune evasion mechanisms. Adenosine, a key metabolite accumulating in hypoxic tumor regions, has emerged as a...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-05-01
|
| Collection: | Biomarker Research |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s40364-025-00784-0 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|